129 related articles for article (PubMed ID: 27833472)
1. Integrated glycomic analysis of ovarian cancer side population cells.
Zhao R; Liu X; Wang Y; Jie X; Qin R; Qin W; Zhang M; Tai H; Yang C; Li L; Peng P; Shao M; Zhang X; Wu H; Ruan Y; Xu C; Ren S; Gu J
Clin Proteomics; 2016; 13():32. PubMed ID: 27833472
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
3. Dynamic analysis of N-glycomic and transcriptomic changes in the development of ovarian cancer cell line A2780 to its three cisplatin-resistant variants.
Lin G; Zhao R; Wang Y; Han J; Gu Y; Pan Y; Ren C; Ren S; Xu C
Ann Transl Med; 2020 Mar; 8(6):289. PubMed ID: 32355733
[TBL] [Abstract][Full Text] [Related]
4. Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp.
Zhao R; Qin W; Qin R; Han J; Li C; Wang Y; Xu C
Clin Proteomics; 2017; 14():20. PubMed ID: 28546799
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Pancreatic Ductal Adenocarcinoma-Related Aberrant Glycosylations: A Multilateral Approach of Lectin Microarray-Based Tissue Glycomic Profiling With Public Transcriptomic Datasets.
Wagatsuma T; Nagai-Okatani C; Matsuda A; Masugi Y; Imaoka M; Yamazaki K; Sakamoto M; Kuno A
Front Oncol; 2020; 10():338. PubMed ID: 32232009
[TBL] [Abstract][Full Text] [Related]
6. N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease.
Leijon H; Kaprio T; Heiskanen A; Satomaa T; Hiltunen JO; Miettinen MM; Arola J; Haglund C
J Clin Endocrinol Metab; 2017 Nov; 102(11):3990-4000. PubMed ID: 28938401
[TBL] [Abstract][Full Text] [Related]
7. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
8. Glycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functions.
Allam H; Aoki K; Benigno BB; McDonald JF; Mackintosh SG; Tiemeyer M; Abbott KL
J Proteome Res; 2015 Jan; 14(1):434-46. PubMed ID: 25437919
[TBL] [Abstract][Full Text] [Related]
9. Glycomic alterations are associated with multidrug resistance in human leukemia.
Zhang Z; Zhao Y; Jiang L; Miao X; Zhou H; Jia L
Int J Biochem Cell Biol; 2012 Aug; 44(8):1244-53. PubMed ID: 22579717
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of side population cells from the human ovarian cancer cell line SK-OV-3.
Ruan Z; Liu J; Kuang Y
Exp Ther Med; 2015 Dec; 10(6):2071-2078. PubMed ID: 26668597
[TBL] [Abstract][Full Text] [Related]
11. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer.
Akita K; Yoshida S; Ikehara Y; Shirakawa S; Toda M; Inoue M; Kitawaki J; Nakanishi H; Narimatsu H; Nakada H
Int J Gynecol Cancer; 2012 May; 22(4):531-8. PubMed ID: 22367369
[TBL] [Abstract][Full Text] [Related]
12. Glycan profiling using formalin-fixed, paraffin-embedded tissues: Hippeastrum hybrid lectin is a sensitive biomarker for squamous cell carcinoma of the uterine cervix.
Tozawa-Ono A; Kubota M; Honma C; Nakagawa Y; Yokomichi N; Yoshioka N; Tsuda C; Ohara T; Koizumi H; Suzuki N
J Obstet Gynaecol Res; 2017 Aug; 43(8):1326-1334. PubMed ID: 28585749
[TBL] [Abstract][Full Text] [Related]
13. Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-type Lectin (MGL).
Napoletano C; Steentoff C; Battisti F; Ye Z; Rahimi H; Zizzari IG; Dionisi M; Cerbelli B; Tomao F; French D; d'Amati G; Panici PB; Vakhrushev S; Clausen H; Nuti M; Rughetti A
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33019700
[TBL] [Abstract][Full Text] [Related]
14. Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy.
Yang G; Tan Z; Lu W; Guo J; Yu H; Yu J; Sun C; Qi X; Li Z; Guan F
J Proteome Res; 2015 Feb; 14(2):639-53. PubMed ID: 25536294
[TBL] [Abstract][Full Text] [Related]
15. Analysis of glycan-related genes expression and glycan profiles in mice with liver fibrosis.
Yu H; Zhu M; Qin Y; Zhong Y; Yan H; Wang Q; Bian H; Li Z
J Proteome Res; 2012 Nov; 11(11):5277-85. PubMed ID: 23043565
[TBL] [Abstract][Full Text] [Related]
16. Focused Glycomic Profiling With an Integrated Microfluidic Lectin Barcode System.
Shang Y; Zeng Y
Methods Enzymol; 2018; 598():169-196. PubMed ID: 29306434
[TBL] [Abstract][Full Text] [Related]
17. Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.
Zhang QH; Dou HT; Xu P; Zhuang SC; Liu PS
Drug Res (Stuttg); 2015 Mar; 65(3):153-7. PubMed ID: 25504004
[TBL] [Abstract][Full Text] [Related]
18. Sialic Acid Linkage Analysis Refines the Diagnosis of Ovarian Cancer.
Dědová T; Braicu EI; Sehouli J; Blanchard V
Front Oncol; 2019; 9():261. PubMed ID: 31110965
[TBL] [Abstract][Full Text] [Related]
19. Mucin carbohydrate antigens (T, Tn, and sialyl-Tn) in human ovarian carcinomas: relationship with histopathology and prognosis.
Ghazizadeh M; Ogawa H; Sasaki Y; Araki T; Aihara K
Hum Pathol; 1997 Aug; 28(8):960-6. PubMed ID: 9269833
[TBL] [Abstract][Full Text] [Related]
20. Identification of aberrantly expressed glycans in gastric cancer by integrated lectin microarray and mass spectrometric analyses.
Li X; Guan F; Li D; Tan Z; Yang G; Wu Y; Huang Z
Oncotarget; 2016 Dec; 7(52):87284-87300. PubMed ID: 27895315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
